Background-Release from prison is associated with a markedly increased risk of both fatal and non-fatal drug overdose, yet the risk factors for overdose in recently released prisoners are poorly understood. The aim of this study was to identify risk and protective factors for non-fatal overdose (NFOD) among a cohort of illicit drug users in Vancouver, Canada, according to recent incarceration.
Introduction
Release from prison is associated with a markedly increased risk of fatal drug overdose, particularly in the weeks immediately following discharge. Evidence from record linkage studies suggests that the risk of drug-related death is orders of magnitude higher among exprisoners than among their community peers (Binswanger et al., 2007; Farrell & Marsden, 2008; Kariminia et al., 2007; Rosen, Schoenbach, & Wohl, 2008; Stewart, Henderson, Hobbs, Ridout, & Knuiman, 2004) , and between 3 and 8 times higher in the first two weeks than the subsequent ten weeks (Merrall et al., 2010) . Although it is often assumed that the key driver of overdose risk for ex-prisoners is reduced drug tolerance (Merrall et al., 2010; Seaman, Brettle, & Gore, 1998; Strang et al., 2003) , empirical support for this view remains weak (Kinner, 2010) .
Reducing the incidence of overdose among recently released prisoners requires an understanding of who is most at risk and why, so that interventions to prevent or effectively respond to overdose events can be appropriately targeted and tailored (Darke, 2008) . Unfortunately, although record linkage studies have identified that ex-prisoners are at increased risk of overdose death, limitations of routinely collected data mean that few risk factors for fatal overdose in this population have been identified (Kinner, 2010) . Existing evidence suggests that those most at risk have served multiple prison sentences, lack postrelease support from a spouse or partner, and have a history of illicit opiate use (Graham, 2003; Hobbs et al., 2006a; Rosen et al., 2008; Seaman et al., 1998; Singleton, Pendry, Taylor, Farrell, & Marsden, 2003) . Findings regarding age and ethnic minority status have been mixed, with some studies finding that older and ethnic minority ex-prisoners are at greater risk (Hobbs et al., 2006b; Stewart et al., 2004; Tobin, Hua, Costenbader, & Latkin, 2007) , while others have found the converse (Farrell & Marsden, 2005; Graham, 2003) . Perhaps reflecting reduced drug tolerance, one study has identified abstinence from drug use in prison as a risk factor for drug-related death post-release (Singleton et al., 2003) , while engagement in prison-based methadone maintenance treatment (MMT) appears to be protective (Dolan et al., 2005; Kinlock, Gordon, Schwartz, Fitzgerald, & O'Grady, 2009 ).
Nonfatal overdose (NFOD) is estimated to be between 20 and 30 times more common than fatal overdose (Darke, Mattick, & Degenhardt, 2003) , and is associated with significant morbidity (Warner-Smith, Darke, & Day, 2002) . Relatively few studies have explored risk factors for NFOD (Strang, 2002) and although the causes of fatal and non-fatal overdose are likely to be similar (Warner-Smith, Darke, Lynskey, & Hall, 2001 ), very few studies have examined NFOD among ex-prisoners. Most studies of NFOD have followed cohorts of injecting drug users (IDU), and a history of recent incarceration consistently emerges as a key risk factor (Kerr, Fairbairn, et al., 2007; Seal et al., 2001; Yin et al., 2007) . Other identified risk factors include homelessness, a history of multiple arrests and/or imprisonments, longer prison sentences, detoxification in the past year, riskier patterns of injecting such as public injecting and binge drug use, and regular or concurrent use of multiple drugs including heroin, alcohol, benzodiazepines and cocaine (Coffin et al., 2007; Kerr, Fairbairn, et al., 2007; Seal et al., 2001; Sergeev, Karpets, Sarang, & Tikhonov, 2003; Yin et al., 2007) . Consistent with the findings from record linkage studies, MMT appears to be protective (Kerr, Fairbairn, et al., 2007) , as does older age (Coffin et al., 2007; Kerr, Fairbairn, et al., 2007; Seal et al., 2001) . Although empirical evidence remains limited, it has been argued that systemic disease, particularly hepatic disease associated with hepatitis C infection, may increase the risk of overdose (Warner-Smith et al., 2001) .
Given the high incidence of overdose among those recently released from prison, and limited knowledge of the risk factors for NFOD among this population, the aims of the present study were to (a) document the incidence of NFOD among a large cohort of illicit drug users in Vancouver, Canada, separately for those who had and had not experienced incarceration recently, and (b) in a multivariate model, identify risk and protective factors for NFOD among this cohort, separately for those who had and had not experienced incarceration recently.
Methods
The Vancouver Injection Drug Users Study (VIDUS) and AIDS Care Cohort to Evaluate Access to Survival Services (ACCESS) are open prospective cohorts of illicit drug-using individuals who have been recruited through self-referral and street outreach from Vancouver's Downtown Eastside since May 1996. Those recruited into the VIDUS cohort are HIV-negative and must have injected an illicit drug at least once in the past six months. Those recruited into the ACCESS cohort are HIV-positive and must have used an illicit drug other than or in addition to cannabis in the last 30 days. Members of the VIDUS cohort who seroconvert during follow-up are automatically transferred into the ACCESS cohort.
At baseline and every six months, participants in both cohorts provide venous blood samples for HIV and hepatitis C (HCV) testing and complete an interviewer-administered questionnaire covering demographic characteristics, information about drug use and related harms, HIV risk behavior, contact with the criminal justice system and enrolment in drug treatment. All participants provide informed, written consent and receive a CA$20 stipend at each study visit. The study has been approved by the University of British Columbia's Research Ethics Board.
The present analyses included all participants who were enrolled into either VIDUS or ACCESS between May 1996 and May 2010 (N=2515). The primary endpoint was selfreported NFOD during the previous six months. Because the focus of the study was NFOD in the community, interviews conducted in prison settings (n=424) were excluded. Information on the primary drug involved in overdose was collected from 2001 onwards.
Explanatory variables were selected from those identified in the literature and included demographic characteristics, patterns of drug use, methadone maintenance treatment (MMT), HIV and HCV serostatus. Demographic characteristics included age, gender, Aboriginal ancestry, marital status, employment status, living alone and current homelessness. Drug use variables included daily use of heroin, cocaine, speedballs (cocaine and heroin in combination), methamphetamine, morphine, benzodiazepines and >4 alcoholic drinks; binge drug use and public injecting. For those who reported recent incarceration, additional explanatory variables included drug injection in prison and, as a proxy for sentence length, incarceration setting (local/provincial/federal). In Canada, incarceration in local jails typically lasts for days or weeks, sentences in provincial prisons are up to two years less a day, and all sentences of two years or more are served in federal penitentiaries. All time-variant variables referred to the last six months unless otherwise specified.
In order to explore whether the risk factors for NFOD differed as a function of recent incarceration, the sample was divided into those who did and did not report incarceration in the last six months. Within each sub-group, we first graphed the annual crude incidence rate of NFOD per 1000 person years, by dividing the number of NFODs reported in each calendar year (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) by the total person years of observation in that year (defined as the number of observations divided by two), divided by 1000. Next we examined univariate associations between potential explanatory variables and NFOD using Pearson's Chi-Square test and the Wilcoxon Rank Sum test; variables significant at p<0.10 were included in subsequent multivariate analyses. Because the analysis included repeated measures of potential explanatory variables for each participant, we used generalized estimating equations (GEE) for binary outcomes with logit link for the analysis of correlated data, to identify factors independently associated with NFOD (Liang & Zeger, 1986) . Multivariate model building proceeded according to the protocol outlined by Pan (2001) .
Results
Between May 1996 and May 2010 2515 participants were recruited into the study, contributing a total of 21,798 eligible observations across a median of six follow-up visits (IQR=2-14). Among this cohort 829 (33.0%) participants reported a total of 1587 NFODs. Among those recently incarcerated who experienced NFOD, 215 (39%) identified the primary drug involved: 81.4% identified a CNS depressant (typically heroin), while 18.1% identified only a stimulant (typically cocaine). Among those who experienced NFOD and had not been incarcerated recently 637 (62%) identified the primary drug involved: 77.2% identified a CNS depressant and 22.3% identified only a stimulant. Table 1 provides descriptive statistics for those who did and did not report recent incarceration at baseline. Factors positively associated with recent incarceration included younger age; male gender; homelessness; unemployment; prior incarceration; daily use of heroin, cocaine, speedballs, morphine and benzodiazepines; recent binge drug use and public injecting; and history of overdose. Factors negatively associated with recent incarceration at baseline included HIV infection, living alone and MMT. Fig. 1 shows the crude incidence rate of NFOD per 1000 person years of observation, among those who did and did not report recent incarceration, by year 1996-2010. Over this 15 year period those reporting recent incarceration experienced a total of 554 NFODs giving a crude incidence rate of 262.7 per 1000 person years of observation, compared with 1035 NFODs and a crude incidence rate of 117.7 per 1000 person years among those who did not report recent incarceration. Those recently incarcerated were significantly more likely to report recent NFOD (OR=2.13, 95%CI 1.89-2.40, p<0.001).
Factors associated with NFOD among those who did and did not report recent incarceration are shown in Table 2 . Among those who reported recent incarceration, factors significantly associated with NFOD in univariate GEE analyses included younger age; homelessness; daily use of heroin, cocaine, speedballs, methamphetamine and benzodiazepines; binge drug use and public injecting; drug injection while incarcerated; and previous NFOD. MMT and HIV infection were protective. Among those who did not report recent incarceration, the same factors were significant, except that daily alcohol use emerged as an additional risk factor, and both previous (not recent) incarceration and HCV exposure were significantly protective. Given the unexpected protective effect of HIV for those recently incarcerated, we computed all two-way interactions between HIV and other factors significant in the multivariate model. The interaction between HIV and age was significant (p=0.02), and in a subsequent test of interaction effects (see Table 3 ) HIV emerged as protective for those ≤38 years of age (AOR=0.65, 95%CI 0.47-0.88), whereas among those who were HIV negative, being aged >38 years was protective (AOR=0.74, 95%CI 0.58-0.95).
Discussion
In the present study we found that among a large cohort of illicit drug users, the incidence of NFOD was significantly higher among those who had experienced recent incarceration. However, the risk factors for NFOD were very similar for those who had and had not experienced recent incarceration, indicating that preventive interventions designed for community-based illicit drug users may also be appropriate for those recently released from prison. Given that most of the risk factors identified pertain to behaviors and circumstances in the community, preventive interventions delivered prior to release should be coupled with community-based interventions after release (Freudenberg, Daniels, Crum, Perkins, & Richie, 2005; Kinner, 2010; WHO, 2010) .
Although many IDU continue to use and inject drugs in prison (Calzavara et al., 2003; Dolan et al., 2010; Jürgens, Ball, & Verster, 2009 ), much of the debate regarding prevention of overdose in ex-prisoners has focused on reduced drug tolerance (Merrall et al., 2010; Seaman et al., 1998; Strang et al., 2003) . Although we were unable to directly measure drug tolerance, our finding that drug injection in prison was a risk factor for NFOD seems inconsistent with the view that reduced drug tolerance is the overriding risk factor. Although it is highly likely that drug tolerance is one important factor, this study has identified a range of other, modifiable risk factors for NFOD, which are very similar to those identified for illicit drug users who have not been incarcerated recently.
The finding that more frequent, riskier patterns of drug injection was a risk factor for NFOD is not new (Kerr, Fairbairn, et al., 2007) , although this study confirms that the same is true for illicit drug users who have been incarcerated recently. Regardless of recent incarceration, risk of NFOD was increased for those reporting public injection or binge drug use. Previous work has shown that accessing a supervised injection facility (SIF) is associated with a reduction in public drug use and other risky injecting practices (Stoltz et al., 2007) , and that SIFs can reduce overdose morbidity (Kerr, Small, Moore, & Wood, 2007; Kerr, Tyndall, Lai, Montaner, & Wood, 2006) and mortality (Milloy, Kerr, Tyndall, Montaner, & Wood, 2008) . Given the elevated incidence of NFOD among those recently incarcerated in this study, there is a clear case for routinely linking incarcerated IDU with a SIF, where available, both via in-reach before release and as part of a broader case management approach after release from custody.
Also consistent with previous research (Kerr, Fairbairn, et al., 2007; Ochoa et al., 2005) , and regardless of recent incarceration history, risk of NFOD in this study was elevated for those reporting daily use of heroin, benzodiazepines, cocaine or methamphetamines. We were unable to determine whether these drugs were used sequentially or in combination, however our findings demonstrate that a range of drugs -both depressants and stimulants -are implicated in overdose among those recently incarcerated. In addition to cautioning prisoners that their opiate tolerance may be reduced post-release, preventive interventions should incorporate messages about the risk of overdose associated with stimulant drugs such as cocaine and methamphetamine.
Previous studies have identified a link between in-prison MMT and reduced overdose mortality post-release (Dolan et al., 2005; Kinlock et al., 2009) , although it remains unclear whether in-prison MMT confers a direct protective effect through increased opiate tolerance at the point of release, or an indirect protective effect by increasing the likelihood of accessing MMT in the community. In this study, regardless of recent incarceration, current MMT was associated with reduced risk of NFOD, highlighting both the benefits of MMT as a harm reduction measure and the particular importance of continuity in treatment provision for IDU returning from custody to the community (Dolan et al., 2005; Kinner, 2006; Larney, Toson, Burns, & Dolan, 2012; Møller et al., 2010; Palepu et al., 2004; Wang et al., 2008) . Irrespective of recent incarceration, risk of NFOD also decreased with increasing age. Although inconsistent with the view that age-related systemic dysfunction should increase the risk of overdose (Warner-Smith et al., 2001) , these findings are consistent with those of other studies (Coffin et al., 2007; Kerr, Fairbairn, et al., 2007) and may indicate that older illicit drug users are 'aging out' of the risky behaviors that increase risk of NFOD. This interpretation is consistent with evidence that impulse control is a risk factor for NFOD (Hakansson, Schlyter, & Berglund, 2008) and that impulsivity declines with age (Steinberg et al., 2008) .
Among those recently incarcerated, risk of NFOD was lower for those who were HIV positive, although this was only true for younger ex-prisoners. One interpretation of this finding is that among younger ex-prisoners, HIV diagnosis was associated with increased access to care and treatment, and a corresponding reduction in overdose risk behaviors. By contrast, given the high prevalence of HIV among the cohort, among older users remaining uninfected with HIV may have been a marker for lower levels of overdose risk behavior. Although potentially important, it remains unclear why this marginally significant finding was observed and future research could further explore these dynamics.
In this study the most powerful predictor of NFOD was past experience of overdose. Among those who had been incarcerated recently, the risk of NFOD was almost four times greater for those who had also overdosed in the past. This finding adds to a growing literature (Coffin et al., 2007; Darke et al., 2007; Stoové, Dietze, & Jolley, 2009) suggesting that previous overdose experience does not increase the perception of risk for subsequent overdose (Darke & Ross, 1997) , but rather increases risk. In the context of limited resources for prisoner and ex-prisoner health initiatives (Belenko & Peugh, 2005; Levy, 2005) , identification of those most at risk of overdose may allow for more effective allocation of limited resources for prevention. In addition to education and case management, this may include provision of naloxone to those considered at high risk (Ochoa et al., 2005; Wakeman, Bowman, McKenzie, Jeronimo, & Rich, 2009 ).
This study has limitations that should be noted. One limitation is use of self-report, however self-report can be reliable with hard-to-reach populations (Darke, 1998) and is arguably the most appropriate way to measure NFOD, since many NFODs are not attended by emergency services or police and are therefore not documented elsewhere (Darke, Ross, & Hall, 1996; Dietze, Cvetkovski, Rumbold, & Miller, 2000) . Further, we have no reason to believe that NFODs would be differentially reported by those who were and were not recently incarcerated. Second, the binary nature of the outcome -any NFOD in the last six monthsmeans that we under-estimated the incidence of NFOD, because we were unable to determine how many times a participant had overdosed in this time. Again, we have no reason to suspect that this would selectively impact those who were or were not recently incarcerated. Third, due to limited statistical power we were unable to conduct our analyses separately for depressant and stimulant overdoses. Although the vast majority of NFODs in both groups were attributed to depressant drugs (usually heroin), the risk factors for stimulant overdoses may differ, and should be the subject of further investigation. Fourth, our sample was not randomly selected and therefore our findings may not be generalizable to all illicit drug users in Vancouver or elsewhere. A final limitation is that among those recently incarcerated, we were unable to confirm that the NFOD occurred after, rather than before, incarceration. However, the markedly elevated incidence of NFOD among those recently incarcerated is consistent with evidence of increased incidence of fatal OD after release from custody (Binswanger et al., 2007; Farrell & Marsden, 2008; Kariminia et al., 2007; Merrall et al., 2010; Rosen et al., 2008; Stewart et al., 2004) , which suggests that at least the majority of NFODs among those recently incarcerated occurred after release from custody.
In summary, among a large, community-recruited sample of illicit drug users this study identified a range of modifiable risk factors for NFOD, and found that these risk factors were similar for those who had and had not experienced incarceration recently. However, the incidence of NFOD was higher among those incarcerated recently, highlighting the urgent need for implementation of evidence-based preventive measures both before release and importantly, after return to the community. Further research is required to understand the causal mechanisms underpinning overdose in ex-prisoners, so that such interventions can be appropriately targeted and tailored. 
